Skip Navigation

​Vaccine Adjuvants

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +
Vaccine and needle
Vaccine and needle.
Credit: CDC

Vaccines to prevent infectious diseases have saved millions of lives worldwide, yet there remains a need for new and improved vaccines against existing and emerging infections. Efforts to develop safe and effective preventative vaccines increasingly involve the use of adjuvants—substances formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvant discovery and development play critical roles in NIAID’s vaccine development efforts.

What’s New

Candidate H7N9 Avian Flu Vaccine Works Better with Adjuvant—Oct. 7, 2014​

NIH Awards Seven New Vaccine Adjuvant Discovery Contracts—Sept. 29, 2014

NIH Begins Testing H7N9 Avian Influenza Vaccine Candidate: Possible Role For Adjuvants to Be Examined—Sept. 18, 2013

Novel Approach for Influenza Vaccination Shows Promise in Early Animal Testing: New Research Advances Development of Universal Flu Vaccine—May 22, 2013

All Vaccine Research News Releases

News From NIAID-Supported Institutions

Last Updated September 29, 2014

Last Reviewed May 13, 2014